RxDoctor Payments Data

Cori Randall

Family · Ashley, NDNPI 1083182174

Payments from drug & device makers

$1,181in general payments, 2019–2025

Across 70 payments — averaging $16.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$234
  • Boehringer Ingelheim$222
  • Merck$177
  • Bayer$142
  • AstraZeneca$86
  • Novartis$71
  • plus $249 from 9 others

What the payments were for

  • Food & beverage$1,181100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,181 in reported general payments places this provider in the 85th percentile of 496 family providers in North Dakota.

See all family providers in North Dakota

Medicare billing

Part B allowed, 2024
$1,914
Medicare patients
16
Services billed
31

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide34$37,655
FarxigaDapagliflozin Propanediol31$25,521
EliquisApixaban43$22,621
JardianceEmpagliflozin41$21,005
XareltoRivaroxaban35$12,961
Breo ElliptaFluticasone/Vilanterol17$7,502
Potassium Chloride147$2,619
Levothyroxine Sodium210$2,013
Lantus SolostarInsulin Glargine,hum.Rec.Anlog12$1,555
Metoprolol Succinate93$1,425
Mirtazapine57$1,279
Rosuvastatin Calcium53$1,108
Klor-Con M20Potassium Chloride71$1,058
Furosemide218$1,029
Pantoprazole Sodium126$989

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$234$37,65534 claims
AstraZenecaFarxiga$86$25,52131 claims
PfizerEliquis$45$22,62143 claims
Boehringer IngelheimJardiance$222$21,00541 claims
Johnson & JohnsonXarelto$15$12,96135 claims
GSKBreo Ellipta$11$7,50217 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 496 family providers in North Dakota.

Other family in Ashley

See the full list for North Dakota

Where these figures come from

Is this you, or does something look wrong? →